--- title: "Daily Hong Kong Stock Market News Express (Wednesday, October 9)" type: "News" locale: "en" url: "https://longbridge.com/en/news/216263426.md" description: "1. Tencent Holdings Limited repurchased HKD 35.9 billion in the third quarter, repurchasing a total of 250 million shares for a total amount of HKD 88.26 billion, reaching a historical high. 2. Powerlong Real Estate's contracted sales in September 2024 reached approximately RMB 614 million, with a total contracted sales of RMB 9.636 billion in the first three quarters. 3. Hopson Development Holdings' presale amount in September 2024 was RMB 603 million, a year-on-year decrease of 27.3%. 4. CSPC PHARMA obtained market approval for the injection of Omazolomab. 5. Sunac China's contract sales in September 2024 were approximately RMB 1.41 billion, totaling RMB 36.45 billion. 6. China Galaxy Securities' shareholders reduced their holdings by 39.233 million shares, decreasing their stake to 4.57%" datetime: "2024-10-09T01:00:07.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/216263426.md) - [en](https://longbridge.com/en/news/216263426.md) - [zh-HK](https://longbridge.com/zh-HK/news/216263426.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/216263426.md) | [繁體中文](https://longbridge.com/zh-HK/news/216263426.md) # Daily Hong Kong Stock Market News Express (Wednesday, October 9) Individual Stock News 1. According to public information from the Hong Kong Stock Exchange, Tencent Holdings repurchased HKD 35.9 billion worth of shares in the third quarter. In the first three quarters of this year, Tencent has repurchased a total of 250 million shares, with a total repurchase amount of HKD 88.26 billion, reaching a historical high for the same period. 2. Poly Property Group (01238.HK): The group's contracted sales in September 2024 (including the contracted sales of joint control entities and associates) amounted to approximately HKD 614 million and 51,925 square meters. As of September 30, 2024, the group's total contracted sales for the first nine months (including the contracted sales of joint control entities and associates) amounted to approximately HKD 9.636 billion and 905,742 square meters. 3. Hopson Development Holdings (01813.HK) announced that in September 2024, the group and its joint ventures and associates had a presale amount of RMB 603 million, a decrease of 27.3% compared to the same period last year. The presale building area of the group and its joint ventures and associates was approximately 28,000 square meters, a decrease of 47.7% compared to the same period last year. 4. CSPC PHARMA (01093.HK) announced on the Hong Kong Stock Exchange that the injection of Omalizumab developed by the group (trade name: Enyitang®) has obtained approval for marketing from the National Medical Products Administration. 5. Sunac China (01918.HK): In September 2024, the group achieved a contracted sales amount of approximately RMB 1.41 billion, a contracted sales area of approximately 129,000 square meters, and an average contracted sales price of approximately RMB 10,930 per square meter. As of the end of September 2024, the group has accumulated a contracted sales amount of approximately RMB 36.45 billion, a cumulative contracted sales area of approximately 1.792 million square meters, and an average contracted sales price of approximately RMB 20,340 per square meter. 6. China Galaxy Securities (06881.HK): Shareholder Yan Yuqing reduced holdings of 39.233 million H shares on October 7th at an average price of HKD 10.479, involving approximately HKD 4.11 billion. Yan Yuqing's shareholding percentage decreased from 5.63% to 4.57% ### Related Stocks - [TENCENT-R (80700.HK)](https://longbridge.com/en/quote/80700.HK.md) - [Tencent Holdings Limited (TCTZF.US)](https://longbridge.com/en/quote/TCTZF.US.md) - [Tencent Holdings Limited (TCEHY.US)](https://longbridge.com/en/quote/TCEHY.US.md) - [TENCENT (00700.HK)](https://longbridge.com/en/quote/00700.HK.md) - [CSPC PHARMA (01093.HK)](https://longbridge.com/en/quote/01093.HK.md) ## Related News & Research - [Tranche Update on CSPC Pharmaceutical Group Limited's Equity Buyback Plan announced on September 19, 2024.](https://longbridge.com/en/news/280502605.md) - [CSPC Pharma's Profit Falls 10% in 2025; Misses EPS, Revenue Estimates](https://longbridge.com/en/news/280415449.md) - [CSPC Profit Slips but Dividend Rises as China Pharma Shifts to Innovation](https://longbridge.com/en/news/280418974.md) - [Tencent (TCEHY) Brings AI Agents to WeChat's 1 Billion Users as Alibaba and Baidu Race Ahead](https://longbridge.com/en/news/280061085.md) - [Tencent integrates WeChat with OpenClaw AI agent amid China tech battle](https://longbridge.com/en/news/280046413.md)